IP‐10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease
2007; Wiley; Volume: 14; Issue: 4 Linguagem: Inglês
10.1111/j.1468-1331.2006.01637.x
ISSN1468-1331
AutoresDaniela Galimberti, E. Venturelli, Chiara Fenoglio, Carlo Lovati, Ilaria Guidi, D. Scalabrini, Claudio Mariani, Nereo Bresolin, Elio Scarpini,
Tópico(s)GDF15 and Related Biomarkers
ResumoEuropean Journal of NeurologyVolume 14, Issue 4 p. e3-e4 IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease D. Galimberti, D. Galimberti Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorE. Venturelli, E. Venturelli Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Fenoglio, C. Fenoglio Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Lovati, C. Lovati Department of Neurology, University of Milan, Ospedale L. Sacco, Milan, ItalySearch for more papers by this authorI. Guidi, I. Guidi Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorD. Scalabrini, D. Scalabrini Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Mariani, C. Mariani Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorN. Bresolin, N. Bresolin Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorE. Scarpini, E. Scarpini Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this author D. Galimberti, D. Galimberti Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorE. Venturelli, E. Venturelli Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Fenoglio, C. Fenoglio Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Lovati, C. Lovati Department of Neurology, University of Milan, Ospedale L. Sacco, Milan, ItalySearch for more papers by this authorI. Guidi, I. Guidi Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorD. Scalabrini, D. Scalabrini Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorC. Mariani, C. Mariani Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorN. Bresolin, N. Bresolin Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this authorE. Scarpini, E. Scarpini Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy; andSearch for more papers by this author First published: 23 March 2007 https://doi.org/10.1111/j.1468-1331.2006.01637.xCitations: 18 Daniela Galimberti, Department of Neurological Sciences, ''Dino Ferrari'' Center, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Via F. Sforza 35, 20122 Milan, Italy (tel.: ++39 2 55033858; fax: ++39 2 50320430; e-mail: [email protected]). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Galimberti D, Schoonenboom N, Scheltens P, et al. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer's disease. Archives of Neurology 2006; 63: 538–543. 2 Galimberti D, Schoonenboom N, Scheltens P, et al. Intrathecal chemokine levels in Alzheimer's disease and frontotemporal lobar degeneration. Neurology 2006; 66: 146–147. 3 Guidi I, Galimberti D, Lonati S, et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging 2006; 27: 262–269. 4 Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999; 56: 303–308. 5 Antonelli A, Rotondi M, Fallahi P, et al. Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. Journal of Interferon and Cytokine Research 2005; 25: 547–552. 6 Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Current opinion in hematology 2001; 8: 131–136. 7 Devanand DP, Pelton GH, Zamora D, et al. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Archives of Neurology 2005; 62: 975–980. Citing Literature Volume14, Issue4April 2007Pages e3-e4 ReferencesRelatedInformation
Referência(s)